168 related articles for article (PubMed ID: 32819369)
1. A case report of a novel compound heterozygous mutation in a Brazilian patient with deficiency of Interleukin-1 receptor antagonist (DIRA).
Mendonça LO; Grossi A; Caroli F; de Oliveira RA; Kalil J; Castro FFM; Pontillo A; Ceccherini I; Barros MAMT; Gattorno M
Pediatr Rheumatol Online J; 2020 Aug; 18(1):67. PubMed ID: 32819369
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the First Indian Patient and a Novel Deletion Affecting IL1RN.
Mendonca LO; Malle L; Donovan FX; Chandrasekharappa SC; Montealegre Sanchez GA; Garg M; Tedgard U; Castells M; Saini SS; Dutta S; Goldbach-Mansky R; Suri D; Jesus AA
J Clin Immunol; 2017 Jul; 37(5):445-451. PubMed ID: 28503715
[TBL] [Abstract][Full Text] [Related]
3. New variant in the IL1RN-gene (DIRA) associated with late-onset, CRMO-like presentation.
Kuemmerle-Deschner JB; Welzel T; Hoertnagel K; Tsiflikas I; Hospach A; Liu X; Schlipf S; Hansmann S; Samba SD; Griesinger A; Benseler SM; Weber AN
Rheumatology (Oxford); 2020 Nov; 59(11):3259-3263. PubMed ID: 32259833
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil.
Jesus AA; Osman M; Silva CA; Kim PW; Pham TH; Gadina M; Yang B; Bertola DR; Carneiro-Sampaio M; Ferguson PJ; Renshaw BR; Schooley K; Brown M; Al-Dosari A; Al-Alami J; Sims JE; Goldbach-Mansky R; El-Shanti H
Arthritis Rheum; 2011 Dec; 63(12):4007-17. PubMed ID: 22127713
[TBL] [Abstract][Full Text] [Related]
5. A novel mutation of interleukin-1 receptor antagonist (IL1RN) in a DIRA patient from Turkey: Diagnosis and treatment.
Sözeri B; Gerçeker-Türk B; Yıldız-Atıkan B; Mir S; Berdeli A
Turk J Pediatr; 2018; 60(5):588-592. PubMed ID: 30968643
[TBL] [Abstract][Full Text] [Related]
6. Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children.
Signa S; D'Alessandro M; Consolini R; Miniaci A; Bustaffa M; Longo C; Tosca MA; Bizzi M; Caorsi R; Mendonça LO; Pession A; Ravelli A; Gattorno M
Pediatr Rheumatol Online J; 2020 Jun; 18(1):51. PubMed ID: 32546242
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 receptor antagonist deficiency with a novel mutation; late onset and successful treatment with canakinumab: a case report.
Ulusoy E; Karaca NE; El-Shanti H; Kilicoglu E; Aksu G; Kutukculer N
J Med Case Rep; 2015 Jun; 9():145. PubMed ID: 26100510
[TBL] [Abstract][Full Text] [Related]
8. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.
Aksentijevich I; Masters SL; Ferguson PJ; Dancey P; Frenkel J; van Royen-Kerkhoff A; Laxer R; Tedgård U; Cowen EW; Pham TH; Booty M; Estes JD; Sandler NG; Plass N; Stone DL; Turner ML; Hill S; Butman JA; Schneider R; Babyn P; El-Shanti HI; Pope E; Barron K; Bing X; Laurence A; Lee CC; Chapelle D; Clarke GI; Ohson K; Nicholson M; Gadina M; Yang B; Korman BD; Gregersen PK; van Hagen PM; Hak AE; Huizing M; Rahman P; Douek DC; Remmers EF; Kastner DL; Goldbach-Mansky R
N Engl J Med; 2009 Jun; 360(23):2426-37. PubMed ID: 19494218
[TBL] [Abstract][Full Text] [Related]
9. Case report: Novel compound heterozygous
Urbaneja E; Bonet N; Solis-Moruno M; Mensa-Vilaro A; de Landazuri IO; Tormo M; Lara R; Plaza S; Fabregat V; Yagüe J; Casals F; Arostegui JI
Front Immunol; 2024; 15():1381447. PubMed ID: 38646532
[TBL] [Abstract][Full Text] [Related]
10. The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist.
Stenerson M; Dufendach K; Aksentijevich I; Brady J; Austin J; Reed AM
Arthritis Rheum; 2011 Dec; 63(12):4018-22. PubMed ID: 21792839
[TBL] [Abstract][Full Text] [Related]
11. Mutation screening of the IL-1 receptor antagonist gene in chronic non-bacterial osteomyelitis of childhood and adolescence.
Beck C; Girschick HJ; Morbach H; Schwarz T; Yimam T; Frenkel J; van Gijn ME
Clin Exp Rheumatol; 2011; 29(6):1040-3. PubMed ID: 22032624
[TBL] [Abstract][Full Text] [Related]
12. Homozygous IL1RN Mutation in Siblings with Deficiency of Interleukin-1 Receptor Antagonist (DIRA).
Ziaee V; Youssefian L; Faghankhani M; Jazayeri A; Saeidian AH; Vahidnezhad H; Uitto J
J Clin Immunol; 2020 May; 40(4):637-642. PubMed ID: 32170523
[No Abstract] [Full Text] [Related]
13. IL-1 blockade in autoinflammatory syndromes.
Jesus AA; Goldbach-Mansky R
Annu Rev Med; 2014; 65():223-44. PubMed ID: 24422572
[TBL] [Abstract][Full Text] [Related]
14. Novel Majeed Syndrome-Causing LPIN2 Mutations Link Bone Inflammation to Inflammatory M2 Macrophages and Accelerated Osteoclastogenesis.
Bhuyan F; de Jesus AA; Mitchell J; Leikina E; VanTries R; Herzog R; Onel KB; Oler A; Montealegre Sanchez GA; Johnson KA; Bichell L; Marrero B; De Castro LF; Huang Y; Calvo KR; Collins MT; Ganesan S; Chernomordik LV; Ferguson PJ; Goldbach-Mansky R
Arthritis Rheumatol; 2021 Jun; 73(6):1021-1032. PubMed ID: 33314777
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 1 receptor antagonist deficiency presenting as infantile pustulosis mimicking infantile pustular psoriasis.
Minkis K; Aksentijevich I; Goldbach-Mansky R; Magro C; Scott R; Davis JG; Sardana N; Herzog R
Arch Dermatol; 2012 Jun; 148(6):747-52. PubMed ID: 22431714
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of interleukin-1 receptor antagonist responsive to anakinra.
Schnellbacher C; Ciocca G; Menendez R; Aksentijevich I; Goldbach-Mansky R; Duarte AM; Rivas-Chacon R
Pediatr Dermatol; 2013; 30(6):758-60. PubMed ID: 22471702
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Anakinra Therapy for the Deficiency of Interleukin-1 Receptor Antagonist through Clinical Evidence.
Pillai K; Pillai J; Ling J
J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398338
[TBL] [Abstract][Full Text] [Related]
18. Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA.
Gómez-García F; Sanz-Cabanillas JL; Viguera-Guerra I; Isla-Tejera B; Nieto AV; Ruano J
Dermatol Ther (Heidelb); 2018 Dec; 8(4):539-556. PubMed ID: 30392030
[TBL] [Abstract][Full Text] [Related]
19. Treating inflammation by blocking interleukin-1 in humans.
Dinarello CA; van der Meer JW
Semin Immunol; 2013 Dec; 25(6):469-84. PubMed ID: 24275598
[TBL] [Abstract][Full Text] [Related]
20. First clinical description of an infant with interleukin-36-receptor antagonist deficiency successfully treated with anakinra.
Rossi-Semerano L; Piram M; Chiaverini C; De Ricaud D; Smahi A; Koné-Paut I
Pediatrics; 2013 Oct; 132(4):e1043-7. PubMed ID: 24019411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
